Article Correctness Is Author's Responsibility: Drug Combination May Improve Impact of Immunotherapy in Head and Neck Cancer

Newswise imageCheckpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers may have found a way to double down on immunotherapy's effectiveness.
Posted in Uncategorized